Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.38 |
| ▸ | KDM4A | O75164 | 12/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 12/20 | 0.37 |
| ▸ | KDM5A | P29375 | 1/20 | 0.37 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.37 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL6238301 | 0.94 | PAOX (0.39) | PAOXKDM4AKDM4CKDM5AKDM7A | |
| SCHEMBL22599 | 0.94 | KDM4A (0.40) | PAOXKDM4AKDM4CKDM5AKDM7A | |
| SCHEMBL7502000 | 0.94 | KDM4A (0.40) | PAOXKDM4AKDM4CKDM5AKDM7A | |
| Methacrylic Acid SCHEMBL6893904 | 0.92 | KDM4A (0.46) | PAOXKDM4AKDM4CKDM5AKDM7A | |
| Hydrochloric Acid SCHEMBL966902 | 0.92 | KDM4A (0.43) | PAOXKDM4AKDM4CKDM5AKDM7A | |
| Bromide SCHEMBL1061717 | 0.92 | KDM4A (0.39) | PAOXKDM4AKDM4CKDM5AKDM7A | |
| Ammonia Solution, Strong SCHEMBL9070327 | 0.92 | KDM4A (0.39) | PAOXKDM4AKDM4CKDM5AKDM7A | |
| Bromomethane SCHEMBL3331850 | 0.90 | KDM4A (0.38) | PAOXKDM4AKDM4CKDM5AKDM7A | |
| Iodomethane SCHEMBL3333482 | 0.90 | KDM4A (0.38) | PAOXKDM4AKDM4CKDM5AKDM7A | |
| SCHEMBL4859244 | 0.90 | KDM4A (0.46) | PAOXKDM4AKDM4CKDM5AKDM7A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0889940-B1 | ELECTROSPRAYABLE RELEASE COATING | MINNESOTA MINING & MFG (US) | 2000-05-03 | — | — | EP | claimed |
| EP-0889940-A1 | ELECTROSPRAYABLE RELEASE COATING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-01-13 | — | — | EP | claimed |
| US-5858545-A | COMPRISING AN UNSATURATED MONOMER, A POLYSILOXANE HAVING UNSATURATED END GROUPS AND ONE OR MORE NONVOLATILE CONDUCTIVITY ENHANCER SOLUBLE IN THE MONOMER AND NOT INTERFERING WITH THE COPOLYMERIZATION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-01-12 | — | — | US | claimed |
| WO-1997035941-A1 | ELECTROSPRAYABLE RELEASE COATING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-10-02 | — | — | WO | claimed |
| US-20110256219-A1 | Manufacturing Solid Pharmaceutical Dosage Forms With Visible Micro- And Nanostructured Surfaces And Micro- And Nanostructured Pharmaceutical Dosage Form | I-PROPERTY HOLDING CORP. (US) | 2011-10-20 | — | — | US | disclosed |
| US-20110256069-A1 | Pharmaceutical Moire Pill | I-PROPERTY HOLDING CORP. (US) | 2011-10-20 | — | — | US | disclosed |
| US-20110188051-A1 | Secure Tracking Of Tablets | I-PROPERTY HOLDING CORP (US) | 2011-08-04 | — | — | US | disclosed |
| EP-2320875-A1 | SECURE TRACKING OF TABLETS | I-Property Holding Corp. (US) | 2011-05-18 | — | — | EP | disclosed |
| EP-0889940-B1 | ELECTROSPRAYABLE RELEASE COATING | MINNESOTA MINING & MFG (US) | 2000-05-03 | — | — | EP | disclosed |
| EP-0889940-A1 | ELECTROSPRAYABLE RELEASE COATING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-01-13 | — | — | EP | disclosed |
| US-5858545-A | COMPRISING AN UNSATURATED MONOMER, A POLYSILOXANE HAVING UNSATURATED END GROUPS AND ONE OR MORE NONVOLATILE CONDUCTIVITY ENHANCER SOLUBLE IN THE MONOMER AND NOT INTERFERING WITH THE COPOLYMERIZATION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-01-12 | — | — | US | disclosed |
| WO-1997035941-A1 | ELECTROSPRAYABLE RELEASE COATING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110256219-A1 | Manufacturing Solid Pharmaceutical Dosage Forms With Visible Micro- And Nanostructured Surfaces And Micro- And Nanostructured Pharmaceutical Dosage Form | MYH10, MITF, CYP2C19 | PAOX 3773/4885KDM4A 4594/4885KDM4C 3866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.